1-3 of 3
Leyla Mohseninejad
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Similar Efficacy of Ibrutinib Arms across ALPINE and ELEVATE-RR Trials in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison

Mazyar Shadman, Alessandra Tedeschi, Leyla Mohseninejad, Keri Yang, Nicole Lamanna, Sheng Xu, Aileen Cleary Cohen, Swetha Challagulla, Mei Xue, Rhys Williams, Susan M. O'Brien, Jennifer R. Brown, Constantine S. Tam
Journal: Blood
Blood (2023) 142 (Supplement 1): 4655.
https://doi.org/10.1182/blood-2023-179222
Published: 2023
Journal Articles

Zanubrutinib vs FCR in Fit Treatment-Naive Patients with Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison

Talha Munir, Leyla Mohseninejad, Sheng Xu, Milica Jevdjevic, Walter Bouwmeester, Keri Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6522.
https://doi.org/10.1182/blood-2023-173172
Published: 2023
Journal Articles

Toxicity, Progression-Free Survival, and Quality of Life of Patients Treated with Zanubrutinib Versus Ibrutinib: A Q-TWiST Analysis from the ALPINE Study in Relapsed or Refractory Chronic Lymphocytic Leukemia

Vincent Levy, Tushar Srivastava, Keri Yang, Palash Purkayastha, Raju Gautam, Kaijun Wang, Leyla Mohseninejad
Journal: Blood
Blood (2023) 142 (Supplement 1): 1909.
https://doi.org/10.1182/blood-2023-173540
Published: 2023